(2025)
Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay.
CRITICAL REVIEWS IN MICROBIOLOGY.
1,
1
(2025)
Comparison of initial treatments for resectable hepatocellular carcinoma within Milan criteria : an observational study based on a nationwide survey.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
108,
5
(2025)
Viral manipulation of host cell glutamine metabolism and glutamine rewiring in hepatic diseases.
CLINICAL AND MOLECULAR HEPATOLOGY.
1,
1
(2025)
The Ubiquitin-Proteasome System in Hepatitis B Virus Infection and Hepatocarcinogenesis: Viral Manipulation and Therapeutic Targets.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY.
35,
(2024)
Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA.
VIRUSES-BASEL.
16,
12
(2024)
Suppression of SARS-CoV-2 nucleocapsid protein dimerization by ISGylation and its counteraction by viral PLpro.
FRONTIERS IN MICROBIOLOGY.
15,
(2024)
Gender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection.
ANIMAL CELLS AND SYSTEMS.
28,
1
(2024)
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction.
CLINICAL AND MOLECULAR HEPATOLOGY.
30,
3
(2024)
Correspondence on editorial regarding "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction".
CLINICAL AND MOLECULAR HEPATOLOGY.
30,
4
(2024)
Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
JOURNAL OF VIROLOGY.
98,
6
(2024)
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis.
BRITISH JOURNAL OF PHARMACOLOGY.
181,
19
(2024)
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.
JOURNAL OF GENERAL VIROLOGY.
105,
5
(2024)
Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma.
DRUG RESISTANCE UPDATES.
73,
1
(2024)
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.
EXPERIMENTAL AND MOLECULAR MEDICINE.
56,
1
(2023)
3D hepatic organoid production from human pluripotent stem cells.
DIFFERENTIATION.
135,
135
(2023)
Cell-permeable peptide nucleic acid antisense oligonucleotide platform targeting human betacoronaviruses.
FRONTIERS IN MICROBIOLOGY.
14,
1
(2023)
The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner.
CANCER COMMUNICATIONS.
44,
2
(2022)
Paraoxonase-2 contributes to promoting lipid metabolism and mitochondrial function via autophagy activation.
SCIENTIFIC REPORTS.
12,
1
(2022)
Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma.
CANCERS.
14,
15
(2022)
Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir.
BIOMEDICINES.
10,
7
특허/프로그램
B형 간염 바이러스에서의 c-FLIP 단백질의 용도.
10-2018-0028015.
20200302.
대한민국
약제 내성 B형 간염 바이러스의 검출 방법.
10-2018-0028014.
20200302.
대한민국